DROPPING TODAY Biotechnology $1.28B Cap Quant: HOLD

Why Is Zymeworks Inc. (ZYME) Stock Down Today?

Updated Nov 17, 2026 6:30 PM ET · Prev Close $26.45

Pro Workspace
Last Session Price
$26.03 -1.59%
-$0.42 vs $26.45 prior close
Intraday Range
$25.53 – $26.52
Open $26.45
Relative Volume
0.12x Avg
216,735 sh
52-Week Range
$21.52 – $31.97
Benchmark Alpha
-0.68% vs SPY
-0.80% vs QQQ
20-Session Trend -7.4%

Primary Move Catalyst & Conviction

65% Signal Conviction
SECTOR 65% Driver Weight

Pharmaceuticals & Therapeutics sector moving together

This appears to be a sector-wide move. The Pharmaceuticals & Therapeutics sector is down 1.9% on average.

Volume Confirmation
LOW VOLUME (0.12x) Unconfirmed
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 65%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

ZYME lagging the S&P 500 by -0.68%
ZYME Session
-1.59%
$26.03
S&P 500 (SPY)
-0.91%
$733.21
Nasdaq 100 (QQQ)
-0.79%
$656.55
Healthcare (XLV)
-0.94%
$186.12
Alpha vs SPY: -0.68% Alpha vs QQQ: -0.80% Alpha vs XLV: -0.65%
Peer Group: Pharmaceuticals & Therapeutics (-1.9% avg) Lagging peers by -0.7%

Options Flow & Execution Desk

Neutral Flow · P/C 1.17
Call Volume
18,031
Contracts
Put Volume
21,158
Contracts
Put / Call Ratio
1.17
39,189 total vol
Implied Volatility
89.4%
Chain avg IV

Recent ZYME Catalyst Headlines

Verified Wire
Zymeworks Announces 200 Million Share Repurchase Authorization

Zymeworks intends to commence the Share Repurchase Program with 140.0 million in share repurchases expected through 2028, with flexibility to adjust the pace of repurchases based on market opportunities, cash flow, and e

Yahoo Finance · Nov 16, 2026
Zymeworks Inc. ZYME Misses Q3 Earnings Estimates

Zymeworks ZYME delivered earnings and revenue surprises of -5.00 and 2.72 , respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Yahoo Finance · Nov 09, 2026

1–3 Day Expected Range & Key Level

45% Follow-Through
Lower Bound
$24.99
Short-term support band
Upper Bound
$26.28
Short-term resistance band
Key Inflection Level
$24.47 (support)

Watch for breakdown below $25.76

Technical Regime (ZYME)

MIXED MA TREND
RSI (14)
40.6
Bearish
20-Day SMA
$28.64
Below 20d
50-Day SMA
$27.22
Below 50d
MACD Signal
Bearish
MACD -0.04
ADX (14)
23.2
Moderate trend
10d Momentum
-4.37
Strong downward 10-day pressure

1-Year Historical Move Analogs

32 Events

Sessions in the past year where ZYME moved >3.0% down:

Continuation Rate
46.9%
15/32 sessions
Avg Next-Day Move
-0.06%
T+1 session return
Last analog: Nov 12, 2026 (-8.9%) → Next session: -0.9%

Retail & Crowd Sentiment

Very Bullish
24h Messages
1
1.4x 7d avg
Bullish / Bearish
100.0% / 0.0%
Low buzz
Crowd Discussion Digest

Zymeworks announced a new $200 million share repurchase program, intending to spend approximately $140.0 million through 2028.

About Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentia...

Sector
Healthcare
Market Cap
$1.28B
Employees
273

Get Instant ZYME Catalyst Alerts

Receive an email alert when ZYME triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

ZYME Session & Catalyst FAQ

Why is ZYME stock down today?

This appears to be a sector-wide move. The Pharmaceuticals & Therapeutics sector is down 1.9% on average.

Is ZYME stock a buy or sell right now?

Today's session carries a 65% catalyst conviction score on 0.12x relative volume (low participation). Our multi-factor model currently rates ZYME as HOLD. Review full valuation, quality, and timing signals on the ZYME Buy or Sell Decision Brief →

What is ZYME's intrinsic value and expected trading range?

At $26.03, ZYME's modeled 1-to-3 session range is $24.99 – $26.28, with a key inflection level at $24.47 (support). Compare current price against multi-year cash flow projections in the ZYME Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for ZYME?

RSI at 40.6 reflects soft below-midline momentum. ZYME trades at $26.03 relative to its 20-day SMA ($28.64) and 50-day SMA ($27.22), reflecting a mixed moving-average structure.

Tradestie Flagship Research & Market Hubs